Back to Directory

Sandy Alvarez

Email

salvarez@milabcentral.org

Phone

310-923-6735

Institution

IMPAACT Laboratory Center

Address

IMPAACT Laboratory Center
10090 Wilshire Blvd.
Suite 260
Los Angeles, CA 90024
USA

Request an Update

Affiliated Studies

IMPAACT 2024 : Phase I/II Dose Finding, Safety and Tolerability Study of Daily Rifapentine Combined with Isoniazid (1HP) for Tuberculosis Prevention in Children Less Than 13 Years of Age with and without HIV.

DAIDS Number

Research Area

Study Status

Open to Accrual

IMPAACT 2048/HVTN 145: Phase I Study of the Safety and Pharmacokinetics of VRC07-523LS, ePGT121v1-LS, and PDGM1400LS Alone and in Combination in Breastfeeding Infants

DAIDS Number

Research Area

Study Status

IMPAACT 2037: Open-Label, Phase I Study of the Safety and Pharmacokinetics of PGT121.414.LS alone and in combination with VRC07-523LS in Infants Exposed to HIV-1

DAIDS Number

Research Area

Study Status